IQVIA Holdings | IQV - Current Assets


IQVIA Holdings reported $6.22B in Current Assets for its fiscal quarter ending in March of 2026.





Current Assets Change Date
Accenture USD 28.01B 59.36M Dec/2025
Agilent USD 4.62B 21M Dec/2025
Bruker USD 2.1B 108.9M Mar/2026
Cardinal Health USD 38.06B 1.17B Mar/2026
Celltrion KRW 470.6B 5.07T Dec/2025
Charles River Laboratories USD 1.49B 41.76M Mar/2026
Cigna USD 43.03B 4.78B Mar/2026
Cognizant Technology Solutions USD 7.84B 716M Mar/2026
Computer Programs Systems USD 104.64M 2.07M Dec/2025
Cspc Pharmaceutical CNY 22.25B 359.48M Dec/2025
CVS Health USD 74.82B 103M Mar/2026
Danaher USD 13.94B 1.18B Mar/2026
Dentsply International USD 1.85B 178M Mar/2026
Deva Holding AS TRY 9.13B 1.61B Sep/2023
Dianthus Therapeutics USD 1.12B 710.47M Mar/2026
Divis Laboratories Ltd INR 98.43B 2.38B Sep/2025
Elevance Health USD 67.03B 4.03B Mar/2026
Humana USD 38.08B 5.35B Mar/2026
IBM USD 31.91B 5.03B Mar/2026
Illumina USD 2.74B 551M Mar/2026
Infosys INR 904.58B 153.09B Dec/2025
Kangmei Pharma CNY 7.03B 128.34M Sep/2025
Knight Therapeutics CAD 394.84M 5.86M Dec/2025
Laboratorios Farma EUR 509.33M 128.63M Dec/2023
Laboratory Of America USD 4.56B 538.3M Mar/2026
Malin Corporation EUR 62.6M 26.7M Dec/2024
McKesson USD 57.21B 2.49B Mar/2026
Mettler Toledo International USD 1.33B 30.76M Mar/2026
Organigram Holdings CAD 256.54M 28.35M Dec/2025
Ovoca Bio EUR 1.56M 3.39M Jun/2025
Pharma Mar EUR 273.45M 9.96M Mar/2026
Publicis EUR 23.07B 3.72B Dec/2025
Qiagen NV USD 2B 535.87M Dec/2025
Quest Diagnostics USD 2.57B 188M Mar/2026
Revvity USD 2.13B 111.43M Mar/2026
Sartorius EUR 1.92B 157.2M Mar/2026
Sino Biopharmaceutical CNY 33.82B 9.13B Jun/2025
Thermo Fisher Scientific USD 22.32B 6.39B Mar/2026
Tilray USD 729.32M 28.18M Sep/2025
UnitedHealth USD 91.13B 545M Mar/2026
Veeva Systems USD 8B 885.78M Dec/2025
Veradigm USD 679.65M 131.12M Dec/2022
Waters USD 3.72B 1.73B Mar/2026
Zealand Pharma A/S 15.67B 950.94M Dec/2025
Zz Pientze Pharmaceu CNY 11.43B 728.95M Mar/2026